logo
16:07 May 29

Natco Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1015.90
-159.90 (-13.60%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Natco Pharma Ltd. Financials

Natco Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1015.90
-159.90 (-13.60%)
16:07 May 29
Quality
image/svg+xml

43/100
Medium Financial Strength

Valuation
image/svg+xml

43/100
Mid Valuation

Technical

59/100
Technically Neutral

Strength

7

Weakness

10

Opportunity

1

Threats

0

15.38 %

ROE %

12.80 %

ROA %

79.20

EPS

515.15

BVPS

34.78 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
1944.8 2707.1 3998.8 4429.5 4078.3
Operating Expenses +
1681.3 1771.5 2247.4 2233.5 2641.8
Raw Material
577.7 651 673.9 702.3 796.7
Increase Decrease in Cost
-16.8 -23.7 42.7 -12.5 -106.2
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
444.8 486.7 525 594.5 687.2
Miscellaneous Expenses
792.6 1008.9 1308.6 1281.4 1670.5
Operating Profit
263.5 935.6 1751.4 2196 1436.5
Other Income
99 104.6 128.1 354.5 297.6
Depreciation
142.6 163.8 186.8 235.2 206.6
Interest
17.7 14.5 19.2 23.9 36.7
Profit before tax and exceptio..
202.2 861.9 1673.5 2291.4 1490.8
Exceptional Items
0 0 0 0 0
PBT
202.2 861.9 1673.5 2291.4 1490.8
Provision for Taxation
32.2 146.6 285.2 408 118.9
Net Profit
170 715.3 1388.3 1883.4 1371.9
NET Profit after MI
170 715.3 1388.3 1885.4 1418.5
EPS
9.32 39.18 77.34 105.26 79.2
Operating Profit Margin (%)
13.55 34.56 43.8 49.58 35.22
Net Profit Margin (%)
8.74 26.42 34.72 42.56 34.78

Natco Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 49.40 49.50 49.50 49.60 49.60 49.60
FII 17.40 15.20 14.10 15.50 17.50 17.90
Public 5.40 5.40 5.90 5.80 5.60 5.60
Others 27.80 29.90 30.50 29.10 27.30 26.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: